Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
91%
Infectious Disease
86%
Hepatitis B Virus
66%
Spike
46%
COVID-19
41%
Hepatitis B
41%
Virus
37%
Gene Mutation
33%
Tumor Necrosis Factor
33%
P53
33%
Viral Load
33%
Colorectal Carcinoma
33%
Virology
33%
Taxon
33%
Microbiology
33%
Intestine Flora
33%
HBsAg
33%
Hepatitis B Antigen
33%
Nicotiana benthamiana
33%
Receptor Binding
33%
Ribonucleic Acid
33%
Pseudomonas aeruginosa
33%
Monoclonal Antibody
33%
Necrotizing Fasciitis
33%
Herpes Zoster
33%
Infectious Agent
33%
Human Immunodeficiency Virus
33%
Antibiotic Sensitivity
22%
Susceptibility
22%
Mortality Rate
21%
Glycoprotein
20%
Cell Culture
20%
Prevalence
16%
DNA Virus
16%
Hepatitis B Vaccine
16%
Hepatitis B Vaccination
16%
Amino Acid Substitution
16%
Reverse Transcription Polymerase Chain Reaction
13%
Cell Line
13%
Single Nucleotide Polymorphism
12%
Virus Infectivity
11%
Pneumococcus
11%
Immunocompromised Patient
11%
Soft Tissue
8%
Host Factor
8%
Fasciitis
8%
Vision
8%
Eyelid
8%
Pseudomonas
8%
Keyphrases
Indonesia
76%
Chronic Liver Disease
33%
Gene mutation
33%
Microbiology
33%
Infectious Diseases
33%
P53 Polymorphism
33%
Virology
33%
Cycle Threshold
33%
Tertiary Care Centers
33%
Molecular Profile
33%
Viral Load
33%
Indonesian Patients
33%
Colorectal Cancer
33%
Pulmonary Tuberculosis
33%
Periorbital Necrotizing Fasciitis
33%
Rifampicin-resistant Tuberculosis (RR-TB)
33%
Gut Microbiota Profiles
33%
Clinical Profile
33%
Herpes Zoster Ophthalmicus
33%
Co-host
33%
Advanced HIV Disease
33%
Gut Microbiota
33%
Rifampicin Resistance
33%
TGF-1
33%
Receptor Binding Domain
33%
Pseudomonas Aeruginosa Bacteraemia
33%
Multidrug-resistant Infections
33%
Healthy Controls
33%
Hepatitis B Virus
23%
Necrosis
22%
CRC Patients
22%
Indonesian
22%
Bacteremia
22%
Pseudomonas Aeruginosa (P. aeruginosa)
22%
X Gene mutation
19%
Bacterial Burden
16%
Long-course
16%
Odds Ratio
16%
Treatment Failure
16%
Chest Pain
16%
Sputum Smear
16%
Anemia
16%
Hepatitis B Virus X Gene
14%
Single nucleotide Polymorphism
14%
Surabaya Indonesia
13%
Bacteroidota
11%
Beta Diversity
11%
Antiretroviral Therapy
11%
Fasciitis
11%
Gingerol
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
66%
Infection
43%
SARS Coronavirus
33%
Chronic Liver Disease
33%
Angiotensin Converting Enzyme 2
33%
Benzalkonium Chloride
33%
Infectious Agent
33%
Methicillin-Resistant Staphylococcus Aureus
33%
Community Acquired Pneumonia
33%
Liver Disease
33%
Chimeric Protein
33%
Pneumonia
33%
Antiinfective Agent
22%
Third Generation Cephalosporin
22%
Mortality Rate
11%
Virus Carrier
11%
Carbapenem Derivative
11%
Sultamicillin
11%
Retrospective Study
11%
Ceftriaxone
11%
Imipenem
11%
Beta Lactam
11%
Beta Lactam Antibiotic
11%
Clavulanic Acid
11%
Amoxicillin
11%
Meropenem
11%
Hepatitis B Antigen
7%
Liver Cirrhosis
7%
Liver Cell Carcinoma
7%
Minimum Inhibitory Concentration
7%
Receptor
6%
IC50
6%